Your browser doesn't support javascript.
loading
Generation of induced pluripotent stem cell lines from two patients with Aicardi-Goutières syndrome type 1 due to biallelic TREX1 mutations.
Hänchen, Vanessa; Kretschmer, Stefanie; Wolf, Christine; Engel, Kerstin; Khattak, Shahryar; Neumann, Katrin; Lee-Kirsch, Min Ae.
Afiliação
  • Hänchen V; Department of Pediatrics, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Kretschmer S; Department of Pediatrics, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Wolf C; Department of Pediatrics, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Engel K; Department of Pediatrics, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Khattak S; Stem Cell Engineering Facility, Center for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden, Dresden, Germany.
  • Neumann K; Stem Cell Engineering Facility, Center for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden, Dresden, Germany.
  • Lee-Kirsch MA; Department of Pediatrics, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. Electronic address: minae.lee-kirsch@uniklinikum-dresden.de.
Stem Cell Res ; 64: 102895, 2022 10.
Article em En | MEDLINE | ID: mdl-36027857
ABSTRACT
Mutations in TREX1, encoding three prime repair exonuclease 1, cause Aicardi-Goutières syndrome (AGS) 1, an autoinflammatory disease characterized by neurodegeneration and constitutive activation of the antiviral cytokine type I interferon. Here, we report the generation and characterization of induced pluripotent stem cells (iPSCs) derived from fibroblasts from two AGS patients with biallelic TREX1 mutations. These cell lines offer a unique resource to investigate disease processes in a cell-type specific manner.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferon Tipo I / Células-Tronco Pluripotentes Induzidas Limite: Humans Idioma: En Revista: Stem Cell Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferon Tipo I / Células-Tronco Pluripotentes Induzidas Limite: Humans Idioma: En Revista: Stem Cell Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha